UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25

                        Commission File Number: 01-28911

                           Notification of Late Filing

(Check one)

|_| Form 10-K     |_| Form 11-K     | | Form 10-Q    |_| Form N-SAR
|X| Form 10-KSB


         For Period Ended: September 30, 2003

         [ ] Transition Report on Form 10-K
         [ ] Transition Report on Form 20-F
         [ ] Transition Report on Form 11-K
         [ ] Transition Report on Form 10-Q
         [ ] Transition Report on Form N-SAR

         For the Transition Period Ended: N/A

         If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:


                                     PART I
                             REGISTRANT INFORMATION

                      NATIONAL HEALTHCARE TECHNOLOGY, INC.
                      ------------------------------------
                             Full name of Registrant


                            -------------------------
                            Former Name if Applicable


                          20700 Ventura Blvd. Suite 227
                          -----------------------------
            Address of principal executive offices(Street and Number)


                        Woodland Hills, California 91364
                        --------------------------------
                            City, State and Zip Code


                                     PART II
                             RULES 12b-25(b) and (c)


         If the subject report could not be filed without unreasonable effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check appropriate box.) [ ] Yes [ ] No

[X]      (a) The reasons described in reasonable detail in Part III of this form
         could not be eliminated without unreasonable effort or expense.

[X]      (b) The subject annual report, semi-annual report, transition report on
         Form 10-K, 20-F, 11-K or N-SAR, or portion thereof, will be filed on or
         before the 15th calendar day following the prescribed due date; or the
         subject quarterly report or transition report on Form 10-Q, or portion
         thereof, will be filed on or before the fifth calendar day following
         the prescribed due date.

[ ]      The accountants's statement or other exhibit required by Rule 12b-25(c)
         has been attached if applicable.





                                    PART III
                                    NARRATIVE

State below in reasonable  detail the reasons why Form 10-K,  11-K,  20-F, 10-Q,
N-SAR, or the transition  report or portion  thereof,  could not be filed within
the prescribed time period.

         The  Registrants's  annual  report on Form  10-KSB  will be filed on or
before the fifteenth  calendar following the prescribed due date. The reason for
the delay is that the Registrant is waiting for certain information from a third
party.


                                     PART IV
                                OTHER INFORMATION

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
     notification:

Charles Smith               (818)              227-9494
- -------------              ----------------------------
(Name)                     (Area Code)(Telephone Number)

(2)  Have all other periodic  reports  required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940  during the  preceding  12 months or such  shorter  period that the
     registrant was required to file such report(s) been filed? If answer is no,
     identify report(s). [x] Yes [ ] No

(3)  Is it anticipated  that any significant  change in results of operation for
     the corresponding  period for the last fiscal year will be reflected by the
     earnings  statements  to be  included  in the  subject  report  or  portion
     thereof? [ ] Yes [x] No

     If so, attach an explanation of anticipated  change,  both  narratively and
     quantitatively,  and if  appropriate,  state the reasons  why a  reasonable
     estimate of the results cannot be made.


                      NATIONAL HEALTHCARE TECHNOLOGY, INC.
                      ------------------------------------
                  (Name of Registrant as Specified in Charter)

                Has caused this notification to be signed on its
               behalf by the undersigned hereunto duly authorized.


Date December 31, 2003                   By: /s/ Charles Smith
                                             --------------------------
                                             Charles Smith, CFO


         Instruction:  The form may be signed  by an  executive  officer  of the
         registrant or by any other duly authorized representative. The name and
         title of the person signing the form shall be typed or printed  beneath
         the  signature.  If the statement is signed on behalf of the registrant
         by  an  authorized   representative  (other  than  executive  officer),
         evidence  of the  representative=s  authority  to sign on behalf of the
         registrant shall be filed with the form.


                                    ATTENTION

         Intention   misstatements  or  omissions  of  fact  constitute  Federal
criminal violations. (See 18 U.S.C. 1001)